Abstract
Abstract Myocardial protection is an essential component of cardiac surgery. Cardioplegic solutions induce cardiac arrest in order to optimise operative conditions. Importantly, cardioplegia enhances myocardial recovery and improves clinical outcomes. There have been considerable advances in myocardial protection since the concept of chemical cardioplegia was first introduced in 1955. Methods can be characterised according to solution, temperature, additives and delivery methods. In spite of significant research, there is still no clear consensus on the cardioplegic method or solution associated with optimum clinical outcomes. This is a comprehensive and comparative overview of the available and upcoming methods in the field of myocardial protection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
